4. Post-marketing safety study to evaluate the occurrence of aseptic meningitis syndrome (AMS) in an adult population (⩾18 years) treated with doses of ⩾1 g/kg INTRAGAM10®
- Resource Type
- Abstract
- Source
- In
Clinical Neurophysiology March 2020 131(3):e2-e2 - Subject
- Language
- ISSN
- 1388-2457